Studies were performed in vivo to measure anti-tumor activity and drug properties; orally-dosed CCX559 had significant anti-tumor efficacy in two murine models, accumulated in the tumors, and induced the reversible internalization of PD-L1. This evidence concerns the gene CD274 and neoplasm.